Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Vericel Corporation
ATQPCurrent price
39.4 EUR
0 EUR (0.00%)
Last closed
40.8 EUR
Company
–
ISIN
US92346J1088
Sector
Healthcare
Industry
Biotechnology
Exchange
Berlin Exchange
Capitalization
2 100 028 605 EUR
Yield for 12 month
+24.68 %
1Y
3Y
5Y
10Y
15Y
ATQP
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in North America. The company markets autologous cell therapy products comprising MACI, an autologous cultured chondrocytes on porcine collagen membrane for the repair of symptomatic, and single or multiple full-thickness cartilage defects of the knee; Epicel, a permanent skin replacement humanitarian use device for the treatment of adult and pediatric patients with deep-dermal or full-thickness burns; and NexoBrid, a biological orphan product for eschar removal in adults with deep partial-thickness and/or full-thickness thermal burns. The company was formerly known as Aastrom Biosciences, Inc. Vericel Corporation was incorporated in 1989 and is headquartered in Cambridge, Massachusetts. Address: 64 Sidney Street, Cambridge, MA, United States, 02139
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
58.69 EURP/E ratio
4080Dividend Yield
–Current Year
+178 245 944 EUR
Last Year
+148 329 222 EUR
Current Quarter
+47 524 190 EUR
Last Quarter
+46 277 923 EUR
Current Year
+122 348 934 EUR
Last Year
+99 076 863 EUR
Current Quarter
+33 030 133 EUR
Last Quarter
+31 904 793 EUR
Key Figures ATQP
1 year
3 years
5 years
10 years
EBITDA
1 187 693 EUR
Operating Margin TTM
PE Ratio
4080
Return On Assets TTM
-0.7 %
PEG Ratio
–
Return On Equity TTM
0.36 %
Wall Street Target Price
58.69 EUR
Revenue TTM
215 371 043 EUR
Book Value
4.99 EUR
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
14.7 %
Dividend Yield
–
Gross Profit TTM
110 223 550 EUR
Earnings per share
0.01 EUR
Diluted Eps TTM
0.01 EUR
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
104.5 %
Profit Margin
0.37 %
Dividend Analytics ATQP
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History ATQP
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:20
Payout Ratio
–
Last Split Date
16.10.2013
Dividend Date
–
Stock Valuation ATQP
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
4080
Forward PE
71.9424
Enterprise Value Revenue
10.4517
Price Sales TTM
9.7507
Enterprise Value EBITDA
310.5829
Price Book MRQ
8.8521
Financials ATQP
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators ATQP
For 52 weeks
29.32 EUR
48.99 EUR
50 Day MA
43.96 EUR
Shares Short Prior Month
–
200 Day MA
41.51 EUR
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart